Ozempic vs Wegovy vs Compounded Semaglutide: What Is the Difference?
Ozempic vs Wegovy, compounded semaglutide, and how Mounjaro (tirzepatide) differs. The same molecule under different labels, the indications, and why supervision matters.
Published December 13, 2024 · Updated June 13, 2026 · 3 min read
The short answer
Ozempic and Wegovy are brand names for the same active molecule, semaglutide. They differ mainly in their approved indication and dosing: Ozempic is approved for type 2 diabetes, Wegovy for weight management. Compounded semaglutide is prepared by a pharmacy. Regardless of form, physician supervision matters for safe dosing and monitoring.
Same molecule, different labels
Ozempic and Wegovy both contain semaglutide. The practical difference is how they are labeled and dosed: Ozempic is approved for type 2 diabetes, while Wegovy is approved for chronic weight management, at doses studied for that use.
That is why two people can be on the same underlying medication under different brand names. The molecule is the same; the approved indication and dosing differ.
What compounded semaglutide is, and why supervision matters
Compounded semaglutide is prepared by a compounding pharmacy rather than supplied as a brand-name product. It became more common during periods when the branded versions were in short supply. Quality and consistency depend heavily on the pharmacy and the physician overseeing it.
Whatever form you use, the medication works the same way in the body and carries the same need for careful titration, side-effect management, and lab monitoring. That oversight is the part that keeps treatment safe, which is why we run it as a supervised program rather than a one-time prescription.
Mounjaro (tirzepatide) vs Ozempic (semaglutide)
A common question is whether Mounjaro is the same as Ozempic. It is not. Ozempic is semaglutide, which acts on a single gut-hormone pathway (GLP-1). Mounjaro is tirzepatide, a different molecule that acts on two pathways (GLP-1 and GIP). Zepbound is that same tirzepatide approved for weight management, the way Wegovy is the weight-management version of semaglutide.
The practical difference between Mounjaro and Ozempic is that the dual action of tirzepatide has produced larger average weight loss in head-to-head and trial data, though individual results vary and tolerability differs from person to person. Both are taken as a once-weekly injection and both need the same careful titration and monitoring.
Which one fits is a clinical decision, not a ranking. Your history, your goals, how you tolerate the medication, and what is actually available all factor in, and a physician can move between options as your response and the supply picture change. We run either as a supervised program rather than a one-off prescription.